Report Detail
Global Overactive Bladder Treatment Market Insights, Forecast to 2025
- RnM2953541 |
- 16 February, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Other
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).
North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2016, North America accounts for 49.59%.
Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.
The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.
The global Overactive Bladder Treatment market is valued at 4710 million US$ in 2018 and will reach 7230 million US$ by the end of 2025, growing at a CAGR of 5.5% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Overactive Bladder Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Overactive Bladder Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Overactive Bladder Treatment in these regions.
This research report categorizes the global Overactive Bladder Treatment market by top players/brands, region, type and end user. This report also studies the global Overactive Bladder Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Astellas Pharma
Allergan
Pfizer
Teva (Activas)
Johnson & Johnson
Market size by Product
Anticholinergics
Mirabegron
Botox
Market size by End User
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Overactive Bladder Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Overactive Bladder Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Overactive Bladder Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Overactive Bladder Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Overactive Bladder Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Overactive Bladder Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Overactive Bladder Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Overactive Bladder Treatment Market Size Growth Rate by Product
- 1.4.2 Anticholinergics
- 1.4.3 Mirabegron
- 1.4.4 Botox
- 1.5 Market by End User
- 1.5.1 Global Overactive Bladder Treatment Market Size Growth Rate by End User
- 1.5.2 Idiopathic Overactive Bladder
- 1.5.3 Neurogenic Overactive Bladder
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Overactive Bladder Treatment Market Size
- 2.1.1 Global Overactive Bladder Treatment Revenue 2014-2025
- 2.1.2 Global Overactive Bladder Treatment Sales 2014-2025
- 2.2 Overactive Bladder Treatment Growth Rate by Regions
- 2.2.1 Global Overactive Bladder Treatment Sales by Regions
- 2.2.2 Global Overactive Bladder Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Overactive Bladder Treatment Sales by Manufacturers
- 3.1.1 Overactive Bladder Treatment Sales by Manufacturers
- 3.1.2 Overactive Bladder Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Overactive Bladder Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Overactive Bladder Treatment Revenue by Manufacturers
- 3.2.1 Overactive Bladder Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Overactive Bladder Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Overactive Bladder Treatment Price by Manufacturers
- 3.4 Overactive Bladder Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Overactive Bladder Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Overactive Bladder Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Overactive Bladder Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Overactive Bladder Treatment Sales by Product
- 4.2 Global Overactive Bladder Treatment Revenue by Product
- 4.3 Overactive Bladder Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Overactive Bladder Treatment Breakdown Data by End User
6 North America
- 6.1 North America Overactive Bladder Treatment by Countries
- 6.1.1 North America Overactive Bladder Treatment Sales by Countries
- 6.1.2 North America Overactive Bladder Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Overactive Bladder Treatment by Product
- 6.3 North America Overactive Bladder Treatment by End User
7 Europe
- 7.1 Europe Overactive Bladder Treatment by Countries
- 7.1.1 Europe Overactive Bladder Treatment Sales by Countries
- 7.1.2 Europe Overactive Bladder Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Overactive Bladder Treatment by Product
- 7.3 Europe Overactive Bladder Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Overactive Bladder Treatment by Countries
- 8.1.1 Asia Pacific Overactive Bladder Treatment Sales by Countries
- 8.1.2 Asia Pacific Overactive Bladder Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Overactive Bladder Treatment by Product
- 8.3 Asia Pacific Overactive Bladder Treatment by End User
9 Central & South America
- 9.1 Central & South America Overactive Bladder Treatment by Countries
- 9.1.1 Central & South America Overactive Bladder Treatment Sales by Countries
- 9.1.2 Central & South America Overactive Bladder Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Overactive Bladder Treatment by Product
- 9.3 Central & South America Overactive Bladder Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Overactive Bladder Treatment by Countries
- 10.1.1 Middle East and Africa Overactive Bladder Treatment Sales by Countries
- 10.1.2 Middle East and Africa Overactive Bladder Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Overactive Bladder Treatment by Product
- 10.3 Middle East and Africa Overactive Bladder Treatment by End User
11 Company Profiles
- 11.1 Astellas Pharma
- 11.1.1 Astellas Pharma Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Astellas Pharma Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Astellas Pharma Overactive Bladder Treatment Products Offered
- 11.1.5 Astellas Pharma Recent Development
- 11.2 Allergan
- 11.2.1 Allergan Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Allergan Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Allergan Overactive Bladder Treatment Products Offered
- 11.2.5 Allergan Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer Overactive Bladder Treatment Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Teva (Activas)
- 11.4.1 Teva (Activas) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Teva (Activas) Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Teva (Activas) Overactive Bladder Treatment Products Offered
- 11.4.5 Teva (Activas) Recent Development
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Johnson & Johnson Overactive Bladder Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Johnson & Johnson Overactive Bladder Treatment Products Offered
- 11.5.5 Johnson & Johnson Recent Development
12 Future Forecast
- 12.1 Overactive Bladder Treatment Market Forecast by Regions
- 12.1.1 Global Overactive Bladder Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Overactive Bladder Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Overactive Bladder Treatment Market Forecast by Product
- 12.2.1 Global Overactive Bladder Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Overactive Bladder Treatment Revenue Forecast by Product 2019-2025
- 12.3 Overactive Bladder Treatment Market Forecast by End User
- 12.4 North America Overactive Bladder Treatment Forecast
- 12.5 Europe Overactive Bladder Treatment Forecast
- 12.6 Asia Pacific Overactive Bladder Treatment Forecast
- 12.7 Central & South America Overactive Bladder Treatment Forecast
- 12.8 Middle East and Africa Overactive Bladder Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Overactive Bladder Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Overactive Bladder Treatment . Industry analysis & Market Report on Overactive Bladder Treatment is a syndicated market report, published as Global Overactive Bladder Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Overactive Bladder Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
